Patents by Inventor Joseph CACACCIO

Joseph CACACCIO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11083793
    Abstract: Compounds including a tetrapyrrolic or reduced tetrapyrrolic group/moiety and an epidermal growth factor receptor targeting group are disclosed. For example, a compound includes a tetrapyrrolic or reduced tetrapyrrolic group or moiety, a linker moiety, an epidermal growth factor receptor targeting group, and, optionally, a PET-active functional group. Uses of the compounds, for example, methods of treating a hyperproliferative tissue in an individual, and kits including one or more of the compounds are also provided.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: August 10, 2021
    Assignees: Health Research, Inc., Photolitec, LLC
    Inventors: Ravindra K. Pandey, Heinz Baumann, Khurshid Guru, Ravindra Cheruku, Erin Tracy, Farukh Durrani, Joseph Cacaccio, Kevin Siters
  • Publication number: 20210236840
    Abstract: New advantageous compositions and methods for treatment of malignancies such as basel cell carcinoma and other skin cancers, brain tumors, head and neck cancer, kidney cancer, prostate cancer and other cancer types. The new compositions and methods may also be used for treatment of non-cancer problems such as dermatological diseases, sexual diseases, anti-fungal and antibacterial and wound healing. A new photodynamic therapy/sonodynamic therapy (PDT/SDT) combination approach using near infrared (NIR) tetrapyrrolic photosensitizers (PSs) with long wavelength absorption, in the range of 750-800 nm, that provides deeper tissue penetration. Such combinations may be postloaded onto PAA nanoparticles (NPs) for better delivery to a tumor site. A preferred sonodynamic compound is fullerene 60 but other sonodynamic compounds may be employed. The unique NP formulations of the invention can contain chemotherapeutic agents releasable by ultrasound in cancer or other hyperproliferative tissue.
    Type: Application
    Filed: January 30, 2020
    Publication date: August 5, 2021
    Inventors: Ballav Borah, Ravindra Pandey, Joseph Cacaccio, Farukh Durrani, Adam Sumlin, Eric Kauffman
  • Publication number: 20200078461
    Abstract: Compounds including a tetrapyrrolic or reduced tetrapyrrolic group/moiety and an epidermal growth factor receptor targeting group are disclosed. For example, a compound includes a tetrapyrrolic or reduced tetrapyrrolic group or moiety, a linker moiety, an epidermal growth factor receptor targeting group, and, optionally, a PET-active functional group. Uses of the compounds, for example, methods of treating a hyperproliferative tissue in an individual, and kits including one or more of the compounds are also provided.
    Type: Application
    Filed: December 13, 2017
    Publication date: March 12, 2020
    Inventors: Ravindra K. PANDEY, Heinz BAUMANN, Khurshid GURU, Ravindra CHERUKI, Erin TRACY, Farukh DURRANI, Joseph CACACCIO, Kevin SITERS